Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin

References

• Akima K, Ito H, Iwata Y, et al. (1996). Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity. J Drug Target 4:1–8
   PubMed Web of Science ®Google Scholar
• Al-Ahmady ZS, Al-Jamal WT, Bossche JV, et al. (2012). Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo. ACS Nano 6:9335–46
   PubMed Web of Science ®Google Scholar
• Du JZ, Du XJ, Mao CQ, et al. (2011). Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc 133:17560–3
   PubMed Web of Science ®Google Scholar
• Elbayoumi TA, Torchilin VP. (2010). Current trends in liposome research. Methods Mol Biol 605:1–27
   PubMedGoogle Scholar
• Eliaz RE, Nir S, Marty C, Szoka FC Jr. (2004). Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Res 64:711–8
   PubMed Web of Science ®Google Scholar
• Eliaz RE, Szoka FC Jr. (2001). Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res 61:2592–601
   PubMed Web of Science ®Google Scholar
• Ellens H, Bentz J, Szoka FC. (1984). pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry 23:1532–8
   PubMed Web of Science ®Google Scholar
• Fry DW, White JC, Goldman ID. (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem 90:809–15
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727–41
   PubMed Web of Science ®Google Scholar
• Gouaze V, Mirault ME, Carpentier S, et al. (2001). Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol Pharmacol 60:488–96
   PubMed Web of Science ®Google Scholar
• Herrera-Gayol A, Jothy S. (1999). Adhesion proteins in the biology of breast cancer: contribution of CD44. Exp Mol Pathol 66:149–56
   PubMed Web of Science ®Google Scholar
• Hope MJ, Mui B, Ansell S, Ahkong QF. (1998). Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid based drugs. J Mol Membr Biol 15:1–14
   PubMed Web of Science ®Google Scholar
• Ishida T, Kirchmeier MJ, Moase EH, et al. (2001). Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim Biophys Acta 1515:144–58
   PubMed Web of Science ®Google Scholar
• Ishida T, Maeda R, Ichihara M, et al. (2003). Accelerated clearance of PEGylated liposomes in rats after repeated injections. J Control Release 88:35–42
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim SJ, Kim BJ, et al. (2006). Doxorubicin-induced reactive oxygen species generation and intracellular Ca2 + increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med 38:535–45
   PubMed Web of Science ®Google Scholar
• Kono K, Igawa T, Takagishi T. (1997). Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative. Biochim Biophys Acta 1325:143–54
   PubMed Web of Science ®Google Scholar
• Lai MZ, Vail WJ, Szoka FC. (1985). Acid- and calcium-induced structural changes in phosphatidylethanolamine membranes stabilized by cholesteryl hemisuccinate. Biochemistry 24:1654–61
   PubMed Web of Science ®Google Scholar
• Lesley J, Hascall VC, Tammi M, Hyman R. (2000). Hyaluronan binding by cell surface CD44. J Biol Chem 275:267–9
   Google Scholar
• Luo Y Prestwich GD. (1999). Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem 10:755–63
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, et al. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–84
   PubMed Web of Science ®Google Scholar
• Manosroi A, Kongkaneramit LL, Manosroi J. (2004). Characterization of amphotericin B liposome formulations. Drug Dev Ind Pharm 30:535–43
   PubMed Web of Science ®Google Scholar
• Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
   PubMed Web of Science ®Google Scholar
• Nayar R, Tilcock CPS, Hope MJ, et al. (1988). N-Succinyldioleoylphosphatidylethanolamine: structural preferences in pure and mixed model membranes. Biochim Biophys Acta 937:31–41
   PubMed Web of Science ®Google Scholar
• Paliwal SR, Paliwal R, Mishra N, et al. (2010). A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy. Curr Cancer Drug Targets 10:343–53
   PubMed Web of Science ®Google Scholar
• Paliwal SR, Paliwal R, Pal HC, et al. (2012). Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Mol Pharm 9:176–86
   PubMed Web of Science ®Google Scholar
• Paliwal SR, Paliwal R, Vyas SP. (2013). pH-sensitive liposomes in drug Delivery. In: Alvarez-Lorenzo C, Concheiro A, eds. RSC smart materials No. 2. Smart materials for drug delivery. Vol. 1. London: The Royal Society of Chemistry, 80–93
   Google Scholar
• Platt VM, Szoka FC Jr. (2008). Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm 5:474–86
   PubMed Web of Science ®Google Scholar
• Rai S, Paliwal R, Vaidya B, et al. (2008). Targeted delivery of doxorubicin via estrone-appended liposomes. J Drug Target 16:455–63
   PubMed Web of Science ®Google Scholar
• Rapoport N. (2007). Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci 32:962–90
   Web of Science ®Google Scholar
• Reddy LH, Murthy RSR. (2004). Pharmacokinetics and biodistribution studies of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Papers 148:161–6
   PubMedGoogle Scholar
• Rothe G, Valet G. (1996). Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J Leukoc Biol 47:440–8
   Google Scholar
• Rudzki Z, Jothy S. (1997). CD44 and the adhesion of neoplastic cells. Mol Pathol 50:57–71
   PubMedGoogle Scholar
• Shen Y, Li Q, Tu J, Zhu J. (2009). Synthesis and characterization of low molecular weight hyaluronic acid-based cationic micelles for efficient siRNA delivery. Carbohydr Polym 77:95–104
   Web of Science ®Google Scholar
• Slepushkin VA, Simoes S, Dazin P, et al. (1997). Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo. J Biol Chem 272:2382–8
   PubMed Web of Science ®Google Scholar
• Straubinger RM. (1993). pH-sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells. Methods Enzymol 221:361–76
   PubMed Web of Science ®Google Scholar
• Straubinger RM, Duzgunes N, Papahadjopoulos D. (1985). pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett 179:148–54
   PubMed Web of Science ®Google Scholar
• Sun P, Zhou D, Gan Z. (2011). Novel reduction-sensitive micelles for triggered intracellular drug release. J Control Release 155:96–103
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carries. Nat Rev 4:45–60
   Google Scholar
• Turakhia S, Venkatakrishnan CD, Dunsmore K, et al. (2007). Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27. Am J Physiol Heart Circ Physiol 293:H3111–21
   Google Scholar
• Upadhyay KK, Bhatt AN, Mishra AK, et al. (2010). The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(g-benzyl L-glutamate)-b-hyaluronan polymersomes. Biomaterials 31:2882–92
   PubMed Web of Science ®Google Scholar
• Wasungu L, Hoekstra D. (2006). Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 116:255–64
   PubMed Web of Science ®Google Scholar
• Webb MS, Hui SW, Steponkus PL. (1993). Dehydration-induced lamellar-to-hexagonal-II phase transitions in DOPE/DOPC mixtures. Biochim Biophys Acta 1145:93–104
   PubMed Web of Science ®Google Scholar
• Yadav AK, Mishra P, Mishra AK, et al. (2007). Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine 3:246–57
   PubMed Web of Science ®Google Scholar
• Yuan F, Dellian M, Fukumura D, et al. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752–6
   PubMed Web of Science ®Google Scholar
• Zeng C, Toole BP, Kinney SD, et al. (1998). Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 77:396–401
   PubMed Web of Science ®Google Scholar
• Zheng C, Yao X, Qiu L. (2011). Novel polymeric vesicles with pH-induced deformation character for advanced drug delivery. Macromol Biosci 11:338–43
   PubMed Web of Science ®Google Scholar